Medical advances mean that people are living longer and consequently have a higher likelihood of surviving longer with illness. Our research contributes to improving the quality of life of people living with life-limiting illnesses.
Who will benefit?
Palliative care is not just end-of-life care. It is also to improve the quality of life of people living with life-limiting illnesses. All Australians with life-limiting illnesses may benefit from our research.
Finding solutions to better manage symptoms experienced by people who need palliative care will improve their quality of life and wellbeing, and may also have a positive impact on their families and carers.
Your donation will help us to run clinical trials that research options for improved management of symptoms using medicines and other interventions.
How do I donate?
You can donate to PaCCSC through the UTS Giving site.
One hundred percent of your donation will go directly to PaCCSC to support our research. Choose PaCCSC from the designation drop-down list on the UTS Giving site. Your donation will be accepted by the University Foundation on our behalf and directed in full to us - all administrative fees are covered by the university.
Can I leave a bequest?
The University of Technology Sydney (UTS) welcomes enquiries to discuss options for bequest giving, including ways to honour someone's memory. Find out more about leaving a bequest through the UTS Giving Leave a Bequest site page.
How will my donation be managed?
UTS is a registered charity with the Australian Charities and Not-for-profits Commission. We have certified Deductible Gift Recipient (DGR) status, with all gifts of $2.00 or more being tax deductible for Australian tax payers.
The UTS Advancement Unit manages the finances of the University Foundation. The Advancement Unit is responsible for overseeing the recording, receiving and acknowledgement of all philanthropic donations, monitoring use of funds in line with donors' wishes, and ensuring fund disbursement to relevant areas of the university.